• State of the Market
    Feb. 25, 2026

    The clinical development technology market transform as life sciences enterprises increasingly rely on digital and AI-enabled solutions to manage rising costs, complex regulatory demands, and longer development cycles. This State of the Market report outlines how…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • PEAK Matrix®
    Nov. 25, 2025

    With global and adaptive clinical trials’ rising complexities, life sciences organizations are increasingly adopting intelligent Randomization and Trial Supply Management (RTSM) platforms to enhance operational efficiency, ensure regulatory compliance, and safeguard patient integrity. RTSM systems have…
  • Provider Compendium
    Dec. 17, 2025

    Life sciences organizations are increasingly prioritizing automation, configurability, and real-time visibility to support modern clinical trial requirements. As adaptive designs, decentralized models, and global multi-protocol studies become more prevalent, the role of Randomization and Trial Supply…
  • Innovation Watch
    March 03, 2026

    As enterprises accelerate AI adoption, managing and retrieving high-dimensional data has become an essential capability. Organizations are increasingly complementing and augmenting traditional databases with vector data platforms purpose-built to store and query embeddings generated through AI…
  • PEAK Matrix®
    March 02, 2023

    Health plans and payer organizations rely on core administration platforms as the foundation of their operations. These platforms facilitate efficient execution of core operational and administrative functions such as benefits administration, claims processing, member enrollment, claims…